Related Experiment Video
Updated: May 30, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Successful Treatment of Palmoplantar Psoriasis With Apremilast in an Immunosuppressed Pediatric Patient on Concurrent
Shawheen J Rezaei1, Danny Linggonegoro1, Shehla Admani1
1Department of Dermatology, Stanford University School of Medicine, Stanford, California, USA.
Abstract:
Immunosuppressive medication may be indicated in patients with severe psoriasis refractory to other treatment modalities. There is a subset of patients, however, who are immunosuppressed at baseline and are not ideal candidates for these agents. Here we report the case of a 15-year-old girl on immunosuppressive medication for preexisting pancolitis and chronic recurrent multifocal osteomyelitis who had an excellent response to concurrent apremilast therapy for her previously refractory palmoplantar psoriasis. These findings support the potential role of apremilast in treating pediatric palmoplantar psoriasis and its utility as an adjunctive therapy in immunosuppressed patients with refractory skin disease.
More Related Videos
02:28Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
09:29Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
Published on: February 1, 2013
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
iPS Cell Differentiation
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids